Evidence map›Paper›PMID 25512376›Full record

ArticleThe Journal of biological chemistry2015

Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.

Chongben Zhang, Gwen Hwarng, Daniel E Cooper, Trisha J Grevengoed, James M Eaton, Viswanathan Natarajan, Thurl E Harris, Rosalind A Coleman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Lipidomic signatures in Colombian adults with metabolic syndrome.Journal of diabetes and metabolic disorders · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Metabolites as regulators of insulin sensitivity and metabolism.Nature reviews. Molecular cell biology · 2018
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chongben ZhangFrom the Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599.
Gwen HwarngFrom the Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599.
Daniel E CooperFrom the Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599.
Trisha J GrevengoedFrom the Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599.
James M Eatonthe Department of Pharmacology, University of Virginia Health System, Charlottesville, Virginia 22908, and.
Viswanathan Natarajanthe Departments of Pharmacology & Medicine, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612.
Thurl E Harristhe Department of Pharmacology, University of Virginia Health System, Charlottesville, Virginia 22908, and.
Rosalind A ColemanFrom the Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599, rcoleman@unc.edu.
University of North Carolina at Chapel Hill · USUniversity of Virginia Health System · USUniversity of Illinois Chicago · US

Funding

Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
METABOLISM OF GLYCEROLIPIDS IN LIVERR01DK056598 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, ROSALIND ANNE · 1999 to 2016
$5.0M
Role of Oxidized neutral lipids in adipocyte functionR01DK101946 · NIDDK · UNIVERSITY OF VIRGINIA · PI HARRIS, THURL E. · 2014 to 2018
$1.7M
Glycerolipid synthesis in liverR56DK056598 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, ROSALIND ANNE · 2017 to 2017
$228k
NHLBI NIH HHS P01 HL098050NHLBI NIH HHS P01 HL98050NIDDK NIH HHS DK56598NIDDK NIH HHS R01 DK056598NIDDK NIH HHS R01 DK101946NIDDK NIH HHS R56 DK056598
6 · The paper itself

Abstract

Although an elevated triacylglycerol content in non-adipose tissues is often associated with insulin resistance, the mechanistic relationship remains unclear. The data support roles for intermediates in the glycerol-3-phosphate pathway of triacylglycerol synthesis: diacylglycerol (DAG), which may cause insulin resistance in liver by activating PKCϵ, and phosphatidic acid (PA), which inhibits insulin action in hepatocytes by disrupting the assembly of mTOR and rictor. To determine whether increases in DAG and PA impair insulin signaling when produced by pathways other than that of de novo synthesis, we examined primary mouse hepatocytes after enzymatically manipulating the cellular content of DAG or PA. Overexpressing phospholipase D1 or phospholipase D2 inhibited insulin signaling and was accompanied by an elevated cellular content of total PA, without a change in total DAG. Overexpression of diacylglycerol kinase-θ inhibited insulin signaling and was accompanied by an elevated cellular content of total PA and a decreased cellular content of total DAG. Overexpressing glycerol-3-phosphate acyltransferase-1 or -4 inhibited insulin signaling and increased the cellular content of both PA and DAG. Insulin signaling impairment caused by overexpression of phospholipase D1/D2 or diacylglycerol kinase-θ was always accompanied by disassociation of mTOR/rictor and reduction of mTORC2 kinase activity. However, although the protein ratio of membrane to cytosolic PKCϵ increased, PKC activity itself was unaltered. These data suggest that PA, but not DAG, is associated with impaired insulin action in mouse hepatocytes.

Indexed as

Signal TransductionAnimalsCarrier ProteinsCells, CulturedDiacylglycerol KinaseDiglyceridesGlycerol-3-Phosphate O-AcyltransferaseHepatocytesInsulinMiceMice, Inbred C57BLPhosphatidic AcidsPhospholipase DProtein Kinase CRapamycin-Insensitive Companion of mTOR ProteinTOR Serine-Threonine KinasesCarrier ProteinsDiacylglycerol KinaseDiglyceridesGlycerol-3-Phosphate O-AcyltransferaseInsulinPhosphatidic AcidsPhospholipase Dphospholipase D1phospholipase D2Protein Kinase CRapamycin-Insensitive Companion of mTOR Proteinrictor protein, mouseTOR Serine-Threonine KinasesDiacylglycerol KinaseGlycerol-3-phosphate AcyltransferaseGlycerophospholipidInsulin ResistanceMammalian Target of Rapamycin (mTOR)Phospholipase DProtein Kinase C (PKC)

Identifiers

PMID25512376
PMCPMC4319019
OpenAlexW1976832709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.